Skip to content
Use caution Drug recall · FDA · Published May 15, 2020

PD-Rx Doxycycline Recall: Failed Dissolution Specs

PD-Rx recalls Doxycycline Hyclate 100 mg tablets due to failed dissolution specifications. Check lot numbers and expiration dates for affected batches.

🇺🇸 FDA recall #D-1276-2020DrugPD-Rx Pharmaceuticals ›
Take action

Contact the company

Recalling firmPD-Rx Pharmaceuticals, Inc.727 N Ann Arbor Ave · Oklahoma City, OK 73127-5822
✎ GovInfoNow plain-language explainer

What happened, in plain English

PD-Rx Pharmaceuticals is recalling specific lots of Doxycycline Hyclate tablets USP, 100 mg because they failed dissolution specifications. This means the medication may not release or absorb properly in the body, potentially reducing its effectiveness. The recall covers 14,030 bottles distributed nationwide across various bottle counts and lot numbers. Read more at govinfonow.com/recall/37118-pd-rx-doxycycline-recall-failed-dissolution-specs.

Source Summary by GovInfoNow · govinfonow.com/recall/37118-pd-rx-doxycycline-recall-failed-dissolution-specs · Updated October 11, 2026 · FDA enforcement record: FDA #D-1276-2020

Cite this page

“PD-Rx Doxycycline Recall: Failed Dissolution Specs.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37118-pd-rx-doxycycline-recall-failed-dissolution-specs. Based on FDA recall #D-1276-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1276-2020%22&limit=1).

Why it’s dangerous

The tablets failed dissolution specifications, which is a quality control measure ensuring the drug breaks down correctly. If the tablets do not dissolve as intended, the active ingredient may not be absorbed effectively by the body. This can lead to subtherapeutic dosing, meaning the antibiotic might not treat the infection properly.

Who’s affected

Patients currently taking Doxycycline Hyclate 100 mg tablets prescribed by PD-Rx Pharmaceuticals are affected. Individuals who have purchased these specific lots between the manufacturing dates and their expiration dates (ranging from June 2020 to January 2021) are at risk of receiving ineffective medication.

How to tell if you have this one

Check your medication bottle for the NDC number starting with 55289-866 and look at the lot number on the label. Affected lots include L18B72, I18B83, H18B11, I18A53, J18F97, K18A33, K18D17, L18A11, L18A29, L18D81, H18F60, I18C26, I18D61, J18B80, K18C97, L18B30, L18D25, L18E50, I18D07, J1E02, J18E62, K18E98, L18C54, H18E18, I18F94, J18E42, L18B56, J18C84, A19B70, K18E92, I18E80, K18A19, F18E11, G18E66, H18E72, I18E75, I18E95, I18F64, A19D44, H18E76, I18F21, and L18B91. Verify the expiration date on the bottle, which ranges from 06/30/2020 to 01/31/2021.

  • Brand
    PD-Rx Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Compare the lot number and NDC on your Doxycycline Hyclate bottle against the recalled list provided in the record.

  2. Contact Your Pharmacist

    If you have an affected lot, speak with your pharmacist immediately to discuss replacing the medication or adjusting your treatment plan.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: May 15, 202012. FDA classified it Class II: May 26, 202023. Published in FDA’s Enforcement Report: Jun 3, 202034. FDA terminated the recall: Nov 8, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1276-2020 (May 15, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1276-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA